Document Detail


C-reactive protein promotes cardiac fibrosis and inflammation in angiotensin II-induced hypertensive cardiac disease.
MedLine Citation:
PMID:  20157054     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
C-reactive protein (CRP) is a risk factor or biomarker for cardiovascular diseases, including hypertension. The present study investigated the functional importance of human CRP in hypertensive cardiac remodeling by a chronic infusion of angiotensin II (Ang II) into mice that express human CRP. Compared with the wild-type mice, although Ang II infusion caused an equally high systolic blood pressure, levels of human CRP were further elevated, and cardiac remodeling was markedly exacerbated in mice that express human CRP, resulting in a significant reduction in the left ventricular ejection fraction and fractional shortening and an increase in cardiac fibrosis (collagen I and III and alpha-smooth muscle actin) and inflammation (interleukin 1beta and tumor necrosis factor-alpha). The enhancement in cardiac remodeling in mice that express human CRP was associated with further upregulation of the Ang II type I receptor and transforming growth factor-beta1 and overactivation of both transforming growth factor-beta/Smad and nuclear factor-kappaB signaling pathways. Furthermore, in vitro studies in cardiac fibroblasts revealed that CRP alone was able to significantly induce expression of the Ang II type I receptor, collagen I/III, and alpha-smooth muscle actin, as well as proinflammation cytokines (interleukin 1beta and tumor necrosis factor-alpha), which was further enhanced by addition of Ang II. In conclusion, CRP is not only a biomarker but also a mediator in Ang II-mediated cardiac remodeling. Enhanced upregulation of the Ang II type I receptor and activation of the transforming growth factor-beta/Smad and nuclear factor-kappaB signaling pathways may be the mechanisms by which CRP promotes cardiac fibrosis and inflammation under high Ang II conditions.
Authors:
Rongxin Zhang; Yuan Yuan Zhang; Xiao R Huang; Yin Wu; Arthur C K Chung; Ed Xuekui Wu; Alexander J Szalai; Benjamin C Y Wong; Chu-Pak Lau; Hui Y Lan
Related Documents :
12714354 - Investigations on the physiological controls of water and saline intake in c57bl/6 mice.
10415044 - Tnf-alpha suppresses ifn-gamma-induced mhc class ii expression in ht1080 cells by desta...
17433074 - Cd59 or c3 are not requred for angiotensin ii-dependent hypertension or hypertrophy in ...
14599844 - Characterization of hla dr2 and dq8 transgenic mouse with a new engineered mouse class ...
1672224 - Participation of noradrenergic neurotransmission in angiotensin iii-induced dipsogenic ...
15098934 - Increased formation of reactive oxygen species, but no changes in glutathione peroxidas...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2010-02-15
Journal Detail:
Title:  Hypertension     Volume:  55     ISSN:  1524-4563     ISO Abbreviation:  Hypertension     Publication Date:  2010 Apr 
Date Detail:
Created Date:  2010-03-18     Completed Date:  2010-04-09     Revised Date:  2010-06-18    
Medline Journal Info:
Nlm Unique ID:  7906255     Medline TA:  Hypertension     Country:  United States    
Other Details:
Languages:  eng     Pagination:  953-60     Citation Subset:  IM    
Affiliation:
Department of Medicine, University of Hong Kong, Hong Kong Special Administrative Region, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Analysis of Variance
Angiotensin II / pharmacology*
Animals
Blood Pressure / drug effects,  genetics
C-Reactive Protein / genetics,  metabolism*
Cells, Cultured
Enzyme-Linked Immunosorbent Assay
Fibrosis / metabolism,  pathology*
Heart / drug effects,  physiopathology
Heart Rate / drug effects
Humans
Hypertension / metabolism,  pathology*,  physiopathology
Immunohistochemistry
Inflammation / genetics,  metabolism,  pathology
Interleukin-1beta / metabolism
Mice
Myocardium / metabolism,  pathology*
Receptor, Angiotensin, Type 1 / metabolism
Reverse Transcriptase Polymerase Chain Reaction
Signal Transduction
Smad Proteins / metabolism
Tumor Necrosis Factor-alpha / metabolism
Up-Regulation
Ventricular Remodeling / genetics*
Chemical
Reg. No./Substance:
0/Interleukin-1beta; 0/Receptor, Angiotensin, Type 1; 0/Smad Proteins; 0/Tumor Necrosis Factor-alpha; 11128-99-7/Angiotensin II; 9007-41-4/C-Reactive Protein
Comments/Corrections
Comment In:
Hypertension. 2010 Jul;56(1):e15; author reply e16   [PMID:  20479326 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Incremental predictive value of adding past blood pressure measurements to the Framingham hypertensi...
Next Document:  Clinical usefulness of positron emission tomography-computed tomography in recurrent thyroid carcino...